Iheanyi E. Okpala

Ituku, EN, Nigeria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.

HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.

Journal: American journal of hematology

Published: July 06, 2026

Preclinical therapeutics for sickle cell disease: modern developments and future considerations.

Preclinical therapeutics for sickle cell disease: modern developments and future considerations.

Journal: Expert opinion on investigational drugs

Published: May 05, 2025

Plasma concentration of fucosyltransferase 7 is not associated with the number of clinically overt vaso-occlusive events in sickle cell disease.

Plasma concentration of fucosyltransferase 7 is not associated with the number of clinically overt vaso-occlusive events in sickle cell disease.

Journal: Ghana medical journal

Published: July 03, 2024

Antiviral response and HIV-1 inhibition in sickle cell disease.

Antiviral response and HIV-1 inhibition in sickle cell disease.

Journal: iScience

Published: April 20, 2023

Effect of Sickle Cell Trait on Human Immunodeficiency Virus Type 1 Infection.

Effect of Sickle Cell Trait on Human Immunodeficiency Virus Type 1 Infection.

Journal: The open AIDS journal

Published: January 23, 2023

Cerebral artery conditional blood velocity in sickle cell disease: a multicentre study and evidence for active treatment.

Cerebral artery conditional blood velocity in sickle cell disease: a multicentre study and evidence for active treatment.

Journal: Archives of disease in childhood

Published: November 17, 2022

Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients.

Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients.

Journal: European journal of haematology

Published: March 24, 2022

Plasma Concentration of 12-Hydroxyeicosatetraenoic Acid, Single Nucleotide Polymorphisms of 12-Lipooxygenase Gene and Vaso-Occlusion in Sickle Cell Disease.

Plasma Concentration of 12-Hydroxyeicosatetraenoic Acid, Single Nucleotide Polymorphisms of 12-Lipooxygenase Gene and Vaso-Occlusion in Sickle Cell Disease.

Journal: Frontiers in genome editing

Published: June 08, 2021

Pilot assessment of omega-3 fatty acids and potassium thiocyanate in sickle cell anemia patients with conditional peak systolic cerebral artery blood velocity.

Pilot assessment of omega-3 fatty acids and potassium thiocyanate in sickle cell anemia patients with conditional peak systolic cerebral artery blood velocity.

Journal: Blood cells, molecules & diseases

Published: January 02, 2021

Clinical and Laboratory Predictors of Frequency of Painful Crises among Sickle Cell Anaemia Patients in Nigeria.

Clinical and Laboratory Predictors of Frequency of Painful Crises among Sickle Cell Anaemia Patients in Nigeria.

Journal: Journal of clinical and diagnostic research : JCDR

Published: January 01, 2017

Frequency and clinical impact of ETV6/RUNX1, AF4-MLL, and BCR/ABL fusion genes on features of acute lymphoblastic leukemia at presentation.

Frequency and clinical impact of ETV6/RUNX1, AF4-MLL, and BCR/ABL fusion genes on features of acute lymphoblastic leukemia at presentation.

Journal: Nigerian journal of clinical practice

Published: February 10, 2016

Investigational selectin-targeted therapy of sickle cell disease.

Investigational selectin-targeted therapy of sickle cell disease.

Journal: Expert opinion on investigational drugs

Published: September 23, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026